[1]
O. Kostiukevych, L. Benkovska, A. Kravchenko, T. Chursina, and K. Mikhaliev, “COVID-19 IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS: THE RISK OF THROMBOEMBOLIC EVENTS AND CURRENT OPTIONS FOR ANTITHROMBOTIC PROPHYLAXIS”, Clin. and prev. med., no. 4, pp. 88-103, Oct. 2022.